• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

历史视角:帕金森病模型。

Historical Perspective: Models of Parkinson's Disease.

机构信息

National Neuroscience Institute, Singapore 308433, Singapore.

Department of Neurology, Singapore General Hospital, Singapore 169856, Singapore.

出版信息

Int J Mol Sci. 2020 Apr 2;21(7):2464. doi: 10.3390/ijms21072464.

DOI:10.3390/ijms21072464
PMID:32252301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7177377/
Abstract

Parkinson's disease (PD) is the most common movement disorder with motor and nonmotor signs. The current therapeutic regimen for PD is mainly symptomatic as the etio-pathophysiology has not been fully elucidated. A variety of animal models has been generated to study different aspects of the disease for understanding the pathogenesis and therapeutic development. The disease model can be generated through neurotoxin-based or genetic-based approaches in a wide range of animals such as non-human primates (NHP), rodents, zebrafish, () , and drosophila. Cellular-based disease model is frequently used because of the ease of manipulation and suitability for large-screen assays. In neurotoxin-induced models, chemicals such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone, and paraquat are used to recapitulate the disease. Genetic manipulation of PD-related genes, such as α-Synuclein(SNCA), Leucine-rich repeat kinase 2 (LRRK2), Pten-Induced Kinase 1 (PINK1), Parkin(PRKN), and Protein deglycase (DJ-1) Are used in the transgenic models. An emerging model that combines both genetic- and neurotoxin-based methods has been generated to study the role of the immune system in the pathogenesis of PD. Here, we discuss the advantages and limitations of the different PD models and their utility for different research purposes.

摘要

帕金森病(PD)是最常见的运动障碍疾病,具有运动和非运动症状。目前 PD 的治疗方案主要是对症治疗,因为其病因病理生理学尚未完全阐明。已经生成了多种动物模型来研究疾病的不同方面,以了解发病机制和治疗开发。该疾病模型可以通过神经毒素或基于遗传的方法在多种动物中生成,如非人类灵长类动物(NHP)、啮齿动物、斑马鱼、()和果蝇。由于易于操作和适合大规模筛选试验,细胞疾病模型经常被使用。在神经毒素诱导的模型中,使用化学物质如 6-羟多巴胺(6-OHDA)、1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)、鱼藤酮和百草枯来重现疾病。PD 相关基因的遗传操作,如 α-突触核蛋白(SNCA)、富亮氨酸重复激酶 2(LRRK2)、Pten 诱导激酶 1(PINK1)、Parkin(PRKN)和蛋白去糖基化酶(DJ-1),用于转基因模型。已经生成了一种结合遗传和神经毒素方法的新兴模型,用于研究免疫系统在 PD 发病机制中的作用。在这里,我们讨论了不同 PD 模型的优缺点及其在不同研究目的中的实用性。

相似文献

1
Historical Perspective: Models of Parkinson's Disease.历史视角:帕金森病模型。
Int J Mol Sci. 2020 Apr 2;21(7):2464. doi: 10.3390/ijms21072464.
2
Experimental models of Parkinson's disease: Challenges and Opportunities.帕金森病的实验模型:挑战与机遇。
Eur J Pharmacol. 2024 Oct 5;980:176819. doi: 10.1016/j.ejphar.2024.176819. Epub 2024 Jul 18.
3
Animal Models for Parkinson's Disease Research: Trends in the 2000s.帕金森病研究的动物模型:21 世纪的趋势。
Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.
4
Animal Models of Parkinson’s Disease帕金森病的动物模型
5
Disease model organism for Parkinson disease: Drosophila melanogaster.帕金森病的疾病模型生物:黑腹果蝇。
BMB Rep. 2019 Apr;52(4):250-258. doi: 10.5483/BMBRep.2019.52.4.204.
6
Animal models of Parkinson's disease: a gateway to therapeutics?帕金森病的动物模型:通往治疗方法的途径?
Neurotherapeutics. 2014 Jan;11(1):92-110. doi: 10.1007/s13311-013-0234-1.
7
Role of Astrocytes in Parkinson's Disease Associated with Genetic Mutations and Neurotoxicants.星形胶质细胞在与基因突变和神经毒素相关的帕金森病中的作用。
Cells. 2023 Feb 15;12(4):622. doi: 10.3390/cells12040622.
8
α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.α-突触核蛋白的单拷贝转基因表达增加了对帕金森病遗传模型中应激的敏感性并加速了神经元的丢失。
Exp Neurol. 2018 Dec;310:58-69. doi: 10.1016/j.expneurol.2018.09.001. Epub 2018 Sep 5.
9
New Developments in Genetic rat models of Parkinson's Disease.帕金森病基因大鼠模型的新进展。
Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.
10
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.

引用本文的文献

1
Effect of nicotine on the energy metabolism of substantia nigra cells in MPTP-induced Parkinson's disease.尼古丁对MPTP诱导的帕金森病中黑质细胞能量代谢的影响。
Iran J Basic Med Sci. 2025;28(10):1417-1427. doi: 10.22038/ijbms.2025.84754.18338.
2
Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal.线粒体应激相关氧化还原信号对呼吸链的表观遗传调控。
Front Cell Dev Biol. 2025 Aug 5;13:1608400. doi: 10.3389/fcell.2025.1608400. eCollection 2025.
3
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
4
Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases.对白质病理学啮齿动物模型在广泛人类疾病中的转化潜力的批判性分析。
Cell Death Dis. 2025 Jul 31;16(1):580. doi: 10.1038/s41419-025-07893-6.
5
Comparative evaluation of MPTP and rotenone as inducing agents for Parkinson's disease in adult zebrafish: Behavioural and histopathological insights.MPTP和鱼藤酮作为成年斑马鱼帕金森病诱导剂的比较评价:行为学和组织病理学见解
Toxicol Rep. 2025 Jul 12;15:102084. doi: 10.1016/j.toxrep.2025.102084. eCollection 2025 Dec.
6
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
7
Ferroptosis in Toxicology: Present and Future.毒理学中的铁死亡:现状与未来
Int J Mol Sci. 2025 Jul 11;26(14):6658. doi: 10.3390/ijms26146658.
8
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.间充质干细胞衍生的细胞外囊泡:神经退行性疾病的新兴疗法
Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.
9
Genetically encoded and modular subcellular organelle probes reveal dysfunction in lysosomes and mitochondria driven by PRKN knockout.基因编码的模块化亚细胞器探针揭示了由PRKN基因敲除驱动的溶酶体和线粒体功能障碍。
iScience. 2025 Jun 3;28(7):112816. doi: 10.1016/j.isci.2025.112816. eCollection 2025 Jul 18.
10
Exploring the Potential Mechanism of Action of Ursolic Acid for Parkinson's Disease: An Integrative Network Pharmacology, Docking and Molecular Dynamics Study.探索熊果酸对帕金森病的潜在作用机制:综合网络药理学、对接和分子动力学研究
Mol Neurobiol. 2025 Jun 24. doi: 10.1007/s12035-025-05145-4.

本文引用的文献

1
Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.使用 3D 类器官作为研究特发性帕金森病模型。
Int J Mol Sci. 2020 Jan 21;21(3):694. doi: 10.3390/ijms21030694.
2
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.在 3D 中脑类器官中建立 G2019S-LRRK2 散发性帕金森病模型。
Stem Cell Reports. 2019 Mar 5;12(3):518-531. doi: 10.1016/j.stemcr.2019.01.020. Epub 2019 Feb 21.
3
Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach.鱼藤酮农药对神经元极化的神经毒性:一种机制研究方法。
Neural Regen Res. 2019 May;14(5):762-766. doi: 10.4103/1673-5374.249847.
4
Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.斑马鱼作为帕金森病和其他运动障碍药物发现的动物模型:一项系统综述。
Front Neurol. 2018 Jun 1;9:347. doi: 10.3389/fneur.2018.00347. eCollection 2018.
5
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.神经毒素诱导的帕金森病动物模型:发病机制与评估。
ASN Neuro. 2018 Jan-Dec;10:1759091418777438. doi: 10.1177/1759091418777438.
6
LRRK2 kinase in Parkinson's disease.帕金森病中的LRRK2激酶
Science. 2018 Apr 6;360(6384):36-37. doi: 10.1126/science.aar5683.
7
Genetic risk factors in Parkinson's disease.帕金森病的遗传风险因素。
Cell Tissue Res. 2018 Jul;373(1):9-20. doi: 10.1007/s00441-018-2817-y. Epub 2018 Mar 13.
8
Modeling Parkinson's Disease in C. elegans.线虫中帕金森病的建模。
J Parkinsons Dis. 2018;8(1):17-32. doi: 10.3233/JPD-171258.
9
Generation of human brain region-specific organoids using a miniaturized spinning bioreactor.使用微型旋转生物反应器生成人类大脑区域特异性类器官。
Nat Protoc. 2018 Mar;13(3):565-580. doi: 10.1038/nprot.2017.152. Epub 2018 Feb 22.
10
C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction.α-突触核蛋白 C 端的钙结合调节突触小泡的相互作用。
Nat Commun. 2018 Feb 19;9(1):712. doi: 10.1038/s41467-018-03111-4.